| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 17 | 2024 | 196 | 2.130 |
Why?
|
| Genome, Bacterial | 7 | 2019 | 64 | 1.130 |
Why?
|
| Microbiota | 7 | 2023 | 106 | 1.110 |
Why?
|
| Dysbiosis | 6 | 2022 | 56 | 0.770 |
Why?
|
| Molecular Typing | 1 | 2019 | 8 | 0.650 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 62 | 0.630 |
Why?
|
| Infection Control | 1 | 2019 | 96 | 0.600 |
Why?
|
| Bacteria | 10 | 2024 | 276 | 0.590 |
Why?
|
| Cross Infection | 1 | 2019 | 151 | 0.580 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2016 | 3 | 0.530 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2016 | 16 | 0.520 |
Why?
|
| Intestines | 5 | 2019 | 157 | 0.480 |
Why?
|
| Anti-Bacterial Agents | 10 | 2024 | 724 | 0.470 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2024 | 330 | 0.460 |
Why?
|
| Metagenomics | 6 | 2019 | 22 | 0.440 |
Why?
|
| Metagenome | 5 | 2016 | 18 | 0.440 |
Why?
|
| RNA, Ribosomal, 16S | 8 | 2022 | 78 | 0.420 |
Why?
|
| Feces | 10 | 2021 | 97 | 0.410 |
Why?
|
| Virulence Factors | 3 | 2012 | 84 | 0.410 |
Why?
|
| Agrobacterium tumefaciens | 2 | 2002 | 3 | 0.400 |
Why?
|
| Clostridium Infections | 2 | 2024 | 46 | 0.400 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 82 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 7 | 2016 | 397 | 0.370 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 105 | 0.350 |
Why?
|
| Intestinal Mucosa | 4 | 2022 | 221 | 0.340 |
Why?
|
| Frailty | 2 | 2022 | 125 | 0.340 |
Why?
|
| Infant | 7 | 2023 | 1527 | 0.340 |
Why?
|
| Phylogeny | 6 | 2020 | 332 | 0.330 |
Why?
|
| Staphylococcal Infections | 3 | 2022 | 114 | 0.290 |
Why?
|
| Humans | 40 | 2024 | 59527 | 0.270 |
Why?
|
| Gastrointestinal Tract | 5 | 2016 | 171 | 0.270 |
Why?
|
| Infant, Newborn | 4 | 2019 | 1311 | 0.260 |
Why?
|
| Bifidobacterium | 2 | 2016 | 16 | 0.260 |
Why?
|
| Infant, Premature | 3 | 2016 | 174 | 0.240 |
Why?
|
| Succinic Acid | 1 | 2024 | 11 | 0.240 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 17 | 0.240 |
Why?
|
| Hyperplasia | 1 | 2024 | 85 | 0.240 |
Why?
|
| Bacterial Proteins | 6 | 2013 | 749 | 0.230 |
Why?
|
| Inflammation | 3 | 2021 | 1102 | 0.230 |
Why?
|
| Microbial Consortia | 2 | 2016 | 7 | 0.230 |
Why?
|
| Specimen Handling | 1 | 2024 | 57 | 0.230 |
Why?
|
| DNA, Bacterial | 5 | 2016 | 260 | 0.230 |
Why?
|
| Staphylococcus aureus | 3 | 2022 | 158 | 0.230 |
Why?
|
| Female | 21 | 2023 | 30924 | 0.220 |
Why?
|
| Male | 18 | 2022 | 27578 | 0.210 |
Why?
|
| Goblet Cells | 1 | 2022 | 8 | 0.210 |
Why?
|
| Membrane Proteins | 3 | 2022 | 842 | 0.200 |
Why?
|
| Genes, Bacterial | 3 | 2012 | 117 | 0.200 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2022 | 12 | 0.200 |
Why?
|
| Plants | 1 | 2002 | 42 | 0.190 |
Why?
|
| Biodiversity | 4 | 2014 | 19 | 0.190 |
Why?
|
| Hyperglycemia | 1 | 2022 | 103 | 0.190 |
Why?
|
| Soft Tissue Infections | 1 | 2022 | 43 | 0.190 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 160 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 76 | 0.190 |
Why?
|
| Ion Channels | 1 | 2002 | 87 | 0.190 |
Why?
|
| Community-Acquired Infections | 1 | 2022 | 87 | 0.190 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 66 | 0.190 |
Why?
|
| Plant Proteins | 1 | 2002 | 83 | 0.180 |
Why?
|
| Bacteremia | 1 | 2022 | 94 | 0.180 |
Why?
|
| Nursing Homes | 3 | 2022 | 665 | 0.180 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 15 | 0.180 |
Why?
|
| Child | 6 | 2024 | 4306 | 0.180 |
Why?
|
| Crohn Disease | 2 | 2020 | 113 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 12 | 0.180 |
Why?
|
| Child, Preschool | 4 | 2019 | 1839 | 0.180 |
Why?
|
| Rectal Fistula | 1 | 2020 | 14 | 0.180 |
Why?
|
| Aged | 9 | 2022 | 13346 | 0.170 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2019 | 4 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 317 | 0.170 |
Why?
|
| Eating | 1 | 2020 | 139 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2069 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 99 | 0.160 |
Why?
|
| Molecular Epidemiology | 1 | 2019 | 26 | 0.160 |
Why?
|
| Proton Pump Inhibitors | 2 | 2021 | 39 | 0.160 |
Why?
|
| Ancylostomiasis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Ancylostoma | 1 | 2019 | 24 | 0.160 |
Why?
|
| Escherichia coli | 4 | 2023 | 685 | 0.160 |
Why?
|
| Disease Outbreaks | 1 | 2019 | 105 | 0.160 |
Why?
|
| Databases, Genetic | 3 | 2014 | 82 | 0.150 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2018 | 5 | 0.150 |
Why?
|
| Virulence | 5 | 2014 | 189 | 0.150 |
Why?
|
| Cluster Analysis | 1 | 2019 | 250 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2002 | 603 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2019 | 139 | 0.150 |
Why?
|
| Mycobiome | 1 | 2017 | 2 | 0.150 |
Why?
|
| Insurance Coverage | 1 | 2018 | 98 | 0.150 |
Why?
|
| Air Microbiology | 1 | 2017 | 7 | 0.150 |
Why?
|
| Lung | 2 | 2015 | 833 | 0.140 |
Why?
|
| Verrucomicrobia | 1 | 2017 | 3 | 0.140 |
Why?
|
| Skin | 3 | 2016 | 353 | 0.140 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2017 | 7 | 0.140 |
Why?
|
| Air Pollution, Indoor | 1 | 2017 | 37 | 0.140 |
Why?
|
| Ethanol | 2 | 2017 | 307 | 0.140 |
Why?
|
| Insurance, Health | 1 | 2018 | 141 | 0.140 |
Why?
|
| Housing | 1 | 2017 | 72 | 0.140 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 61 | 0.140 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 139 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2017 | 87 | 0.130 |
Why?
|
| Biological Evolution | 2 | 2016 | 109 | 0.130 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 3 | 0.130 |
Why?
|
| Animals | 12 | 2024 | 19663 | 0.130 |
Why?
|
| Klebsiella | 1 | 2016 | 9 | 0.130 |
Why?
|
| Prophages | 1 | 2016 | 6 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 97 | 0.130 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2017 | 84 | 0.130 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2017 | 74 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 135 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 1131 | 0.130 |
Why?
|
| Carbohydrates | 1 | 2015 | 42 | 0.130 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 5092 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 3195 | 0.120 |
Why?
|
| Cognition | 1 | 2019 | 459 | 0.120 |
Why?
|
| Young Adult | 4 | 2019 | 4332 | 0.120 |
Why?
|
| Oropharynx | 1 | 2015 | 12 | 0.120 |
Why?
|
| Mice | 8 | 2024 | 10280 | 0.120 |
Why?
|
| Infant, Premature, Diseases | 1 | 2015 | 46 | 0.120 |
Why?
|
| Adolescent | 4 | 2019 | 5932 | 0.120 |
Why?
|
| Geologic Sediments | 1 | 2014 | 5 | 0.120 |
Why?
|
| Neutrophils | 1 | 2017 | 357 | 0.120 |
Why?
|
| Soil Microbiology | 1 | 2014 | 8 | 0.120 |
Why?
|
| Stomach | 1 | 2015 | 84 | 0.120 |
Why?
|
| RNA, Bacterial | 2 | 2012 | 70 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 1 | 2015 | 77 | 0.120 |
Why?
|
| Enterobacter | 1 | 2014 | 5 | 0.110 |
Why?
|
| Brucellaceae | 1 | 2013 | 1 | 0.110 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2024 | 17 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2016 | 203 | 0.110 |
Why?
|
| Adult | 7 | 2020 | 15791 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2018 | 1135 | 0.110 |
Why?
|
| Survival Rate | 1 | 2016 | 791 | 0.110 |
Why?
|
| Genomics | 2 | 2013 | 314 | 0.110 |
Why?
|
| Middle Aged | 6 | 2021 | 16279 | 0.110 |
Why?
|
| Massachusetts | 1 | 2019 | 2089 | 0.110 |
Why?
|
| Colitis, Ulcerative | 2 | 2012 | 84 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 551 | 0.110 |
Why?
|
| Acinetobacter | 1 | 2012 | 2 | 0.110 |
Why?
|
| Acinetobacter Infections | 1 | 2012 | 5 | 0.100 |
Why?
|
| Colon | 2 | 2024 | 137 | 0.100 |
Why?
|
| Vancomycin Resistance | 1 | 2012 | 4 | 0.100 |
Why?
|
| Rhodobacter sphaeroides | 1 | 2012 | 7 | 0.100 |
Why?
|
| Prochlorococcus | 1 | 2012 | 3 | 0.100 |
Why?
|
| Daptomycin | 1 | 2012 | 9 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 42 | 0.100 |
Why?
|
| Sepsis | 1 | 2015 | 281 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2022 | 1063 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2010 | 7 | 0.090 |
Why?
|
| Pouchitis | 1 | 2010 | 8 | 0.090 |
Why?
|
| Environment | 1 | 2011 | 125 | 0.090 |
Why?
|
| Artifacts | 1 | 2011 | 126 | 0.080 |
Why?
|
| Haemophilus influenzae | 1 | 2009 | 26 | 0.080 |
Why?
|
| Haemophilus Infections | 1 | 2009 | 15 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2020 | 74 | 0.080 |
Why?
|
| Models, Biological | 3 | 2017 | 1142 | 0.080 |
Why?
|
| Homeostasis | 2 | 2021 | 342 | 0.070 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 699 | 0.070 |
Why?
|
| Liver | 3 | 2017 | 785 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2019 | 3101 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2016 | 367 | 0.070 |
Why?
|
| Software | 3 | 2016 | 367 | 0.060 |
Why?
|
| Ohio | 2 | 2017 | 26 | 0.060 |
Why?
|
| Biomarkers | 1 | 2011 | 1211 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2020 | 2442 | 0.060 |
Why?
|
| Base Sequence | 2 | 2011 | 1313 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2022 | 6011 | 0.060 |
Why?
|
| Point-of-Care Testing | 1 | 2024 | 42 | 0.060 |
Why?
|
| United States | 3 | 2024 | 7514 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2024 | 113 | 0.060 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 30 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 2 | 2015 | 48 | 0.060 |
Why?
|
| Species Specificity | 2 | 2016 | 337 | 0.060 |
Why?
|
| Feeding Methods | 1 | 2023 | 9 | 0.050 |
Why?
|
| Parturition | 1 | 2023 | 53 | 0.050 |
Why?
|
| Proteobacteria | 2 | 2014 | 7 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2023 | 39 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2023 | 38 | 0.050 |
Why?
|
| DNA, Ribosomal | 2 | 2014 | 29 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1470 | 0.050 |
Why?
|
| Leukocidins | 1 | 2022 | 8 | 0.050 |
Why?
|
| Exotoxins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 52 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 99 | 0.050 |
Why?
|
| Prebiotics | 1 | 2022 | 12 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2023 | 92 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 143 | 0.050 |
Why?
|
| Genes, rRNA | 2 | 2012 | 7 | 0.050 |
Why?
|
| Fever | 1 | 2022 | 63 | 0.050 |
Why?
|
| Plants, Genetically Modified | 1 | 2002 | 22 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 195 | 0.050 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 39 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2022 | 60 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 183 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2013 | 149 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 106 | 0.050 |
Why?
|
| Weight Gain | 1 | 2022 | 161 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2012 | 183 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 2470 | 0.050 |
Why?
|
| Furunculosis | 1 | 2020 | 2 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2020 | 14 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2020 | 24 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 906 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2020 | 33 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 250 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 376 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2020 | 77 | 0.040 |
Why?
|
| Diet, Mediterranean | 1 | 2020 | 32 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 208 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 233 | 0.040 |
Why?
|
| Binding Sites | 1 | 2002 | 875 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2024 | 1989 | 0.040 |
Why?
|
| Memory, Long-Term | 1 | 2019 | 7 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 44 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 317 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 1373 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2020 | 147 | 0.040 |
Why?
|
| Cricetinae | 1 | 2019 | 377 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 921 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2018 | 40 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2020 | 314 | 0.040 |
Why?
|
| Machine Learning | 1 | 2019 | 136 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2017 | 16 | 0.040 |
Why?
|
| Dust | 1 | 2017 | 42 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2017 | 93 | 0.040 |
Why?
|
| Diet | 1 | 2022 | 635 | 0.030 |
Why?
|
| Organoids | 1 | 2017 | 42 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 735 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 219 | 0.030 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2017 | 33 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1252 | 0.030 |
Why?
|
| Chromatin | 1 | 2002 | 594 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 2017 | 42 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1281 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 375 | 0.030 |
Why?
|
| Income | 1 | 2017 | 160 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 886 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 152 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 52 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 455 | 0.030 |
Why?
|
| Dementia | 1 | 2019 | 247 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2355 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 526 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 601 | 0.030 |
Why?
|
| Esophageal pH Monitoring | 1 | 2015 | 3 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 848 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2015 | 97 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2015 | 35 | 0.030 |
Why?
|
| Bacteroidetes | 1 | 2014 | 5 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2015 | 64 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1186 | 0.030 |
Why?
|
| Disease Vectors | 1 | 2014 | 7 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 20 | 0.030 |
Why?
|
| Gram-Positive Bacteria | 1 | 2014 | 36 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2014 | 37 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 61 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2015 | 61 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 2014 | 7 | 0.030 |
Why?
|
| Ampicillin | 1 | 2014 | 11 | 0.030 |
Why?
|
| Gentamicins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 117 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2002 | 1457 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 810 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2014 | 82 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 846 | 0.030 |
Why?
|
| Gestational Age | 1 | 2014 | 183 | 0.030 |
Why?
|
| Acinetobacter calcoaceticus | 1 | 2012 | 1 | 0.030 |
Why?
|
| Acinetobacter baumannii | 1 | 2012 | 4 | 0.030 |
Why?
|
| Siderophores | 1 | 2012 | 11 | 0.030 |
Why?
|
| Operon | 1 | 2012 | 34 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2104 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2012 | 7 | 0.030 |
Why?
|
| Liver Abscess | 1 | 2012 | 17 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2012 | 48 | 0.020 |
Why?
|
| Hemolysis | 1 | 2012 | 38 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 137 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 2012 | 13 | 0.020 |
Why?
|
| Laboratories, Hospital | 1 | 2012 | 9 | 0.020 |
Why?
|
| Genome | 1 | 2014 | 253 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 178 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2002 | 2891 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2012 | 166 | 0.020 |
Why?
|
| Programming Languages | 1 | 2011 | 15 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 287 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 141 | 0.020 |
Why?
|
| Cell Wall | 1 | 2012 | 113 | 0.020 |
Why?
|
| Chimera | 1 | 2011 | 42 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 422 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 27 | 0.020 |
Why?
|
| Fusobacteria | 1 | 2010 | 3 | 0.020 |
Why?
|
| Actinobacteria | 1 | 2010 | 7 | 0.020 |
Why?
|
| Bacteroides | 1 | 2010 | 9 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 298 | 0.020 |
Why?
|
| Patients | 1 | 2012 | 102 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
| Genome, Archaeal | 1 | 2010 | 1 | 0.020 |
Why?
|
| Urogenital System | 1 | 2010 | 2 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 79 | 0.020 |
Why?
|
| Checklist | 1 | 2011 | 75 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1538 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 250 | 0.020 |
Why?
|
| Mouth | 1 | 2010 | 32 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 281 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 200 | 0.020 |
Why?
|
| Respiratory System | 1 | 2010 | 42 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1225 | 0.020 |
Why?
|
| Genomic Library | 1 | 2009 | 11 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 926 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 2009 | 42 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 900 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 500 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2329 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 92 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 375 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2009 | 128 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 294 | 0.020 |
Why?
|
| Computational Biology | 1 | 2010 | 325 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5184 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1551 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 324 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 458 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1979 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1449 | 0.020 |
Why?
|
| Peptides | 1 | 2010 | 549 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 2443 | 0.010 |
Why?
|